FDA Grants Abbreviated Approval for Divalproex Sodium by Unichem
The FDA has granted an abbreviated approval for Divalproex Sodium under application ANDA214643 submitted by Unichem.
Asset / Drug
Drug and asset intelligence for Unichem with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.